Is adempas a generic drug?

See the DrugPatentWatch profile for adempas

Is Adempas available as a generic?

Adempas (active ingredient: riociguat) is not available as a generic drug in the information provided. It is marketed as a brand-name medicine.

Could it still be considered “generic” in some sense?

No. “Generic” usually means an FDA-approved (or local regulator–approved) product that uses the same active ingredient and meets approval requirements for equivalence. Without an approved generic version, Adempas does not count as generic.

What to check if you want the real status

To confirm whether a generic or biosimilar equivalent has launched, check:
- The label/brand name on the prescription or medication packaging (brand vs generic listing)
- The pharmacy’s drug listing (whether it offers “riociguat” as a generic)
- Your country’s drug database for riociguat availability

Why this question comes up (patents and exclusivity)

Questions about whether drugs become generic often hinge on patent and exclusivity timelines. If a generic version exists, it typically appears after those protections expire and regulators approve the generic.

Sources

No sources were provided with your question, so I can’t verify the current regulatory/generic status for your country from external references here.